Workflow
限售股上市流通
icon
Search documents
中无人机: 中无人机首次公开发行部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-06-20 13:26
Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for AVIC Chengdu UAV Systems Co., Ltd., with a total of 403,378,057 shares set to be released on June 30, 2025, marking a significant event in the company's stock market activity [1][9]. Summary by Sections 1. Listing of Restricted Shares - The shares being listed are part of the company's initial public offering (IPO) and involve 8 shareholders, representing 59.76% of the total share capital [2][10]. - The total number of shares after the IPO is 675,000,000, with 121,794,229 shares being unrestricted and 553,205,771 shares being restricted [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2]. 3. Commitments Related to Restricted Shares - Shareholders and the actual controller, AVIC, have committed not to transfer or manage the shares for 36 months from the date of listing [2][3]. - If the stock price falls below the issue price for 20 consecutive trading days within the first 6 months, the lock-up period will automatically extend by 6 months [3][4]. 4. Compliance and Verification - As of the announcement date, the shareholders have adhered to their commitments, ensuring no issues that would affect the listing of the restricted shares [9]. - The underwriting institutions, CITIC Securities and AVIC Securities, have confirmed that the listing complies with relevant regulations and commitments [9][10]. 5. Details of Restricted Shares - The total number of restricted shares being listed is 403,378,057, which will transition from restricted to unrestricted status on the specified date [10]. - The breakdown of shareholders holding these restricted shares includes various entities under AVIC, ensuring a concentrated ownership structure [10].
春立医疗: 华泰联合证券有限责任公司关于北京市春立正达医疗器械股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-19 10:01
Core Viewpoint - The report from Huatai United Securities provides a thorough review of the listing and circulation of restricted shares for Beijing Chunli Zhengda Medical Devices Co., Ltd., confirming compliance with relevant regulations and the fulfillment of commitments by shareholders [1][8]. Group 1: Restricted Shares Overview - The restricted shares being listed for circulation are part of the company's initial public offering, involving two shareholders: Mr. Shi Chunbao and Ms. Yue Shujun. The original lock-up period of 36 months has been extended by 6 months due to the fulfillment of commitment conditions, now set to end on June 30, 2025 [2][6]. - The total number of restricted shares being released is 209,133,335, which accounts for 54.52% of the company's total share capital [6][8]. Group 2: Changes in Share Capital - The company's total share capital has changed from 384,280,000 shares to 383,568,500 shares since the formation of the restricted shares [2][4]. Group 3: Shareholder Commitments - Shareholders have made several commitments regarding their restricted shares, including not proposing buybacks and extending the lock-up period if the stock price falls below the IPO price for a specified duration [4][5]. - As of the date of the announcement, the shareholders have adhered to their commitments, ensuring no issues affecting the listing of restricted shares [5][8]. Group 4: Regulatory Compliance - Huatai United Securities has confirmed that the listing and circulation of the restricted shares comply with various regulatory frameworks, including the Securities Issuance and Listing Sponsorship Business Management Measures and the Shanghai Stock Exchange's rules [1][8].
京城股份: 京城股份发行股份及支付现金购买资产并募集配套资金之部分限售股上市流通的公告
Zheng Quan Zhi Xing· 2025-06-17 11:11
Core Points - The announcement details the listing of restricted shares for Beijing Jingcheng Machinery Electric Company Limited, with a total of 7,034,552 shares set to be publicly traded starting June 24, 2025 [1][5][21] - The shares are part of a non-public issuance related to the acquisition of assets and the raising of supporting funds, approved by the China Securities Regulatory Commission [1][2] - The total number of restricted shares issued for asset acquisition amounts to 46,481,314 shares, with specific lock-up periods for different shareholders [2][3] Share Registration and Lock-up Arrangements - The newly issued shares are subject to a 12-month lock-up period for certain shareholders, after which they will be released in stages based on performance compensation agreements [2][8] - The first phase of unlocking allows for 40% of the shares to be released after the 12-month period, contingent on fulfilling performance obligations for 2021 [2][10] - Subsequent phases will release 20% of shares based on the completion of performance obligations for 2022 and 2023 [2][10] Changes in Share Capital - Following the completion of the non-public issuance, the total share capital of the company increased from 485,000,000 shares to 531,481,314 shares, with 109,481,314 shares classified as restricted [4][6] - The company’s total share capital as of the announcement date is 547,665,988 shares, with 19,469,105 shares under restricted conditions [7][8] Compliance and Verification - The independent financial advisor, CITIC Securities, confirmed that the listing of restricted shares complies with relevant laws and regulations, and that there are no violations affecting the listing [21] - The company has committed to adhering to all regulatory requirements and ensuring the independence of its operations post-transaction [16][19]
智翔金泰: 国泰海通证券股份有限公司关于重庆智翔金泰生物制药股份有限公司首次公开发行战略配售限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-12 14:09
Core Viewpoint - The report outlines the verification opinions regarding the listing and circulation of strategic placement restricted shares of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. following its initial public offering on the Sci-Tech Innovation Board [1][5]. Summary by Sections 1. Type of Restricted Shares - The company issued 91,680,000 shares during its IPO, with a total share capital of 366,680,000 shares post-IPO. The restricted shares amount to 2,639,915 shares, representing 0.7200% of the total share capital, with a lock-up period of 24 months starting from June 20, 2023 [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2]. 3. Commitments Related to Restricted Shares - The shareholder, Haitong Innovation Securities Investment Co., Ltd., has committed to a lock-up period of 24 months from the IPO date. After the lock-up period, any reduction in shareholding will comply with the relevant regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3]. 4. Listing and Circulation of Restricted Shares - The restricted shares will be listed and available for circulation on June 20, 2025. The total number of shares for circulation is 2,639,915, which is the entire amount of strategic placement shares [3][4]. 5. Verification Opinions from the Sponsor - The sponsor, Guotai Junan Securities Co., Ltd., confirms that all commitments made by the restricted share shareholders have been strictly adhered to, and the listing and circulation of the restricted shares comply with relevant regulations [4][5].
新安股份: 中信证券股份有限公司关于浙江新安化工集团股份有限公司向特定对象发行股票部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-12 10:28
Group 1 - The core viewpoint of the article is that Citic Securities has conducted a thorough review of Zhejiang Xin'an Chemical Group Co., Ltd.'s issuance of restricted shares to specific investors, confirming compliance with relevant regulations and the successful completion of the share registration process [1][5] - The company issued a total of 203,850,509 shares to 13 specific investors, increasing its total share capital from 1,145,746,540 shares to 1,349,597,049 shares [1][2] - The newly issued shares are subject to a lock-up period of 18 months, with the earliest date for trading being June 17, 2024 [2][3] Group 2 - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2] - The specific investors have committed to not transferring their shares for 18 months following the issuance, and this commitment extends to any shares derived from stock dividends or capital increases [2][5] - The total number of restricted shares that will be listed for trading is 56,625,141, which represents 4.20% of the company's total shares [3][4]
利安科技: 国泰海通证券股份有限公司关于宁波利安科技股份公司首次公开发行股票部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-03 12:20
国泰海通证券股份有限公司 关于宁波利安科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司(以下简称"保荐机构")作为宁波利安科技股 份有限公司(以下简称"利安科技"或"公司")首次公开发行股票并创业板上 市及持续督导的保荐机构,根据《证券发行上市保荐业务管理办法》《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业 《深圳证券交易所上市公司自律监管指引第 13 号——保荐 板上市公司规范运作》 业务》等法律法规的相关规定,对宁波利安科技股份有限公司首次公开发行部分 限售股上市流通事项进行了核查,核查情况及核查意见如下: 一、本次上市流通的限售股类型 中国证券监督管理委员会于 2024 年 1 月 11 日出具《关于同意宁波利安科技 股份有限公司首次公开发行股票注册的批复》 (证监许可202453 号),同意公司 首次公开发行股票的注册申请。公司首次向社会公开发行人民币普通股(A 股) 完成后总股本为 56,237,600 股,其中有限售条件流通股 42,177,600 股,占发行后 总股本的比例为 75%,无限售条件流通股 14,060,00 ...
双元科技: 民生证券股份有限公司关于浙江双元科技股份有限公司首次公开发行战略配售限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-05-29 09:35
Group 1 - The core point of the article is the approval and upcoming listing of strategic placement restricted shares of Zhejiang Shuangyuan Technology Co., Ltd. on the Sci-Tech Innovation Board [1][2][3] - The company was approved by the China Securities Regulatory Commission to publicly issue 14.7857 million shares, with a total share capital of 59.1427 million shares post-issuance [1][2] - The restricted shares involved in this listing are held by one shareholder, accounting for 0.81% of the total share capital, with a lock-up period of 24 months starting from the listing date [2][3] Group 2 - The restricted shares will become tradable on June 9, 2025, due to the preceding day being a non-trading day [2][3] - The shareholder, Minsheng Securities Investment Co., Ltd., has committed to holding the shares for 24 months from the date of the initial public offering [2][3] - The company confirms that there have been no changes in share capital due to profit distribution or other factors since the formation of the restricted shares [2][3]
容知日新: 国元证券股份有限公司关于安徽容知日新科技股份有限公司向特定对象发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-05-11 09:15
Core Viewpoint - The report outlines the verification opinion of Guoyuan Securities regarding the listing and circulation of restricted shares for Anhui Rongzhi Rixin Technology Co., Ltd. after a specific issuance of A-shares to designated investors, confirming compliance with relevant regulations and the commitment of shareholders [1][5]. Group 1: Restricted Shares Issuance - The company has received approval for the issuance of restricted shares, increasing its total share capital from 81,626,048 shares to 87,427,353 shares, with 5,801,305 shares being restricted and 5,076,141 shares set to be listed for circulation [1][2]. - The restricted shares have a lock-up period of 6 months from the end of the issuance, involving 15 shareholders [1][3]. Group 2: Shareholder Commitments - Shareholders of the restricted shares have committed to not transferring their shares during the 6-month lock-up period, and they have adhered to this commitment without any breaches affecting the listing [3][4]. Group 3: Listing Details - A total of 5,076,141 restricted shares will be listed for circulation, representing 5.81% of the company's total share capital, with the listing date set for May 19, 2025 [4][5]. - The detailed list of shareholders holding restricted shares includes various investment funds and asset management companies [4]. Group 4: Verification Opinion - Guoyuan Securities has concluded that the application for the listing of restricted shares complies with all relevant laws and regulations, and the information disclosed by the company is accurate and complete [5].